Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA
NCT03926260
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Non-small Cell Lung Cancer
Interventions
OTHER:
ctDNA analysis
Sponsor
Centre Hospitalier Departemental Vendee